Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| NFAM1 | Q8NET5 | NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1) | Predicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 2 | 0.40 | |||
| NGEF | Q8N5V2 | Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor) | Predicted intracellular proteins | Receptor-signaling mediation | 2 | 0.40 | ||||
| NID2 | Q14112 | Nidogen-2 (NID-2) (Osteonidogen) | Plasma proteinsPredicted intracellular proteinsPredicted secreted proteins | Adhesion and uptake mediation | 2 | 0.40 | ||||
| NLGNX | Q8N0W4 | Neuroligin-4, X-linked (Neuroligin X) (HNLX) | Disease related genesHuman disease related genesPotential drug targets | 1 | Asperger syndromeAutismAutism spectrum disorder | Fusion and delivery mediation | 2 | 0.40 | ||
| NLS1 | Q8NA29 | Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A) (HsMFSD2A) (MFSD2a) | Disease related genesHuman disease related genesPotential drug targets | 12 | Primary microcephaly | Fusion and delivery mediationMetabolism mediation | 2 | 0.40 | ||
| NOTC1 | P46531 | Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | LymphomaMature T-cell lymphomaSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.40 | ||
| NP1L2 | Q9ULW6 | Nucleosome assembly protein 1-like 2 (Brain-specific protein, X-linked) (Histone chaperone NAP1L2) | Other mediation | 2 | 0.40 | |||||
| O10P1 | Q8NGE3 | Olfactory receptor 10P1 (Olfactory receptor 10P2) (Olfactory receptor 10P3) (Olfactory receptor OR12-7) | 7 | Other mediation | 2 | 0.40 | ||||
| OPN3 | Q9H1Y3 | Opsin-3 (Encephalopsin) (Panopsin) | G-protein coupled receptorsPredicted membrane proteins | 7 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 2 | 0.40 | |||
| OPRK | P41145 | Kappa-type opioid receptor (K-OR-1) (KOR-1) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Bipolar disorderChronic painCoronary vasospastic disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.40 |